5[6]Pohlu， Nolte C， Bunse A， etal. Endothelium-dependent phosphorylation of Vasodilator-stimulated protein in platelet during coronary passage[J].Am，J，Physiol，1994，266:H606～12.
6[7]Dzau VJ， Gibbons GH. Endothelium and growth factors in vascular remodeling of hypertension[J]. Hypertension，1991，18:115～21.
1Ghiso N, Rohan RM, Amano S, et al . Suppression of hy poxia- associated vascular endothelial growth factor gene expression by nitric oxide via cGMP[J]. Invest Ophthalmol Vis Sci, 1999,40 (6): 1033.
2Yuan L, Neufeld AH. Tumor necrosis factor- alpha: a potentially neurodestructive cytokine produced by glia in the human glaueomatous optic nerve head[ J]. Glia,2000,32 (1): 42.
3Geyer O, Podos SM, Oron Y, et al .The effect of divalent cations on bovine retinal NOS activity [ J ]. Mol Cell Biohem, 2000, 204(1-2):11.
4Mayhan WG. Nitric oxide accounts for histainin - induced increase in macromolecular extravasation[ J]. AM J Physiol, 1994,266 (6): H2369 ～ H2373.
5Volk T, Loannikdis I, Hensi M, et al . Endothelial damage induced by nitric oxide synergism reactive oxygwn species [ J ].Biochem Biophy Res Commun, 1995,213 (1): 196 ～ 203.
6Pieper GM,Mei DA,Langenstroer P, et al .Bioassay of en dothelium- derived relaxing factor in eiabetic rat aorta [ J ]. Am J Physiol, 1992,263:H676 ～ 680.
7Diederich D,Skopec J,Diedem A, et al . Endothelial dys- function in mesenteric resistance arteries of diabetic rats: role of freeradicals[J]. Am J Physiol, 1994,266(3 Pt 2): H1153 ～ 61.
8Graier WF,Posch K,Wascher TC, et al . Role of superox-ide anions in changes of endothelial vasoactive response during acutehyperglycemia[J]. Horm Melab Res, 1997,29(12): 622 ～ 626.
9Schmetterer L,Polak K. Role of nitric oxide in the controlof ocular blood flow [J]. Prog Retin Eye Kes, 2001,20 (6): 823 ～841.
10Hernandez C, Lecube A, Segura RM, et al . Nitric oxide and vascular endothelial grouth factor concentrations are increased butnot related in vitreous fluid of patients with proliferative diabeticretinopathy[J]. Diabet Med, 2002,19(8) :655 ～ 60.
